• WCG’s eCOA portfolio and imaging analysis technology from NeuroRx are now part of Clario!

menu-close-icon
Your using an unsupported browser. Please update to a modern browser for a better experience.
Skip to content
Clario Clario
  • Solutions
    • Study Endpoints
      • Cardiac Safety IconCardiac Solutions
        • Cardiac Solutions

          Cardiac safety and efficacy endpoint solutions for all phases, anywhere in the world.

        • Arrhythmia Analysis

          Collect continuous ECG data in site-based or hybrid trials with our flexible solutions and patient-friendly devices.

        • Blood Pressure Services

          Collect and centrally analyze accurate, consistent, quality blood pressure data from site-based to hybrid trials.

        • ECG — On-site to DCT and Phase I-IV

          Monitor every heartbeat with precision to assess safety and efficacy throughout your site-based or hybrid clinical trial.

        • Phase I/TQT Cardiac Assessment

          Fulfill your ICH E14 requirement early, minimize risk and potentially reduce costs throughout your trial.

        • Regulatory Consultation and Statistical Analysis Expertise

          Leverage our key opinion leaders to understand the complex regulatory landscape while minimizing risk with confidence.

      • Clinical Adjudication
      • ECOA IconeCOA
        • eCOA Clinical Trials

          Make your clinical trials easier, faster, more engaging and accessible to all.

        • eCOA Live

          Enjoy flexible, fast and confidential site assessments at home.

        • eCOA Multimedia

          Enhance your ePRO data with photo and audio capture.

        • eCOA Rapid Start

          Accelerate your clinical trial setup with Clario’s pre-validated and configured eCOA assessments.

        • eCOA Rater and Participant Training

          Improve data accuracy and reduce variability in scoring with Clario’s training solutions.

        • eCOA Rescue Studies

          Your trusted partner for the richest eCOA endpoint data in your clinical trial.

        • Suicidal Ideation

          Monitor Suicide Ideation and Behavior (SIB) in clinical trials effectively with Clario’s suicide assessment tool, eC-SSRS.

      • Medical ImagingMedical Imaging
        • Medical Imaging

          Accelerate drug development and reduce risk with Clario’s comprehensive medical imaging core lab services.

        • Medical Imaging science team

          The Clario team includes medical imaging experts and globally recognized key opinion leaders (KOLs) representing multiple disciplines.

        • Image Redact AI

          Clario’s Image Redact AI automatically redacts sensitive patient identifiers from videos, photos and PDFs.

        • Imaging Platform

          Secure accurate results, streamline your processes, and meet your unique needs with our imaging platform.

        • Modalities

          Leverage our full range of medical imaging and diagnostic imaging modalities, including CT Scans, Endoscopy, MRIs, and more.

        • SMART Submit

          Securely collect, store, and share de-identified images for compliance with 21 CFR Part 11 and EU GDPR standards.

      • Precision Motion IconPrecision Motion
        • Precision Motion for Clinical Trials

          Clario's complete solution for measuring objective digital endpoints of mobility with wearable sensor technology.

        • Precision Motion for Research

          The Opal V2R® is a research grade wearable sensor that delivers meaningful outcomes and richer insights.

        • Precision Motion: Scientific Publications

          Explore more than 750 scientific publications that reflect the technical and clinical applications of Clario’s Opal® System.

      • Respiratory Solutions IconRespiratory
        • Respiratory Solutions

          Everything you need for high quality, low variability pulmonary function data and high patient compliance for clinical trials.

        • Site-Based Spirometry (FEV1, FVC, PEF, and more.)

          Centralized, on-site pulmonary function testing for clinical trials.

        • Virtual Home Spirometry

          Remote spirometry testing for respiratory clinical trials.

        • Cough and Lung Sounds

          Assess cough frequency, cough severity and other lung sounds such as crackles or rhonchi for clinical trials.

        • Diffusing Capacity (DLCO)

          Assess the capacity of the lungs for effective gas transfer.

      • Trial Enablement IconTrial Enablement
        • Trial Enablement

          Advanced, cloud-native technologies and clinical trial software to screen, clean, QC and assess complicated data.

        • Eligibility Solution

          Collect, centralize and manage participant screening and eligibility data with customized workflows.

        • Reporting & Analytics

          Boost stakeholder insights with business intelligence (BI) tools, analytics for endpoint and safety risks, and data exchange solutions.

        • Source Document Manager

          Securely collect, store and share compliant images in the cloud to keep clinical trial sponsors and labs informed.

    • Segments
      • Biotechs
      • CROs
      • Pharmacist Icon RGBPharma
    • Study Phases
      • Safety Icon RGBPhase I
      • Clinical Trial Management System Icon RGBPhase II/III
    • Technology
      • AI Icon RGBArtificial Intelligence (AI)
      • Hybrid Trials
  • Therapeutic Areas
    • Cardiovascular & Metabolic Icon RGBCardiovascular & Metabolic
    • Dermatology Icon RGBDermatology
    • Type 2 Diabetes and Obesity iconDiabetes and Obesity
    • Gastroenterology Icon RGBGastroenterology
    • Hepatology Icon RGBHepatology
    • Infectious Disease Icon RGBInfectious Diseases
    • Muskoskeletal Icon RGBMusculoskeletal
    • Neuroscience Icon RGBNeuroscience
      • Neuroscience Indications
      • Headache Disorders
      • Movement Disorders
      • Multiple Sclerosis
      • Pain Disorders
      • Psychiatric Disorders
    • Oncology Icon RGBOncology
    • Ophthalmology Icon RGBOphthalmology
    • Respiratory Solutions IconRespiratory
  • Resources
    • Blog Articles
    • Case Studies
    • Downloads
    • Events
    • External Publications
    • Webinars
  • About
    • The Clario Story
    • Careers
    • Corporate & Social Responsibility
    • Information Security
    • Leadership
    • Legal & Privacy
    • Newsroom
    • Scientific Expertise
    • Strategic Partnerships
    • Values & Culture
  • Support
    • Customer Support
    • In-Country Cardiac Safety Support
  • Solutions
    • eCOA Clinical Trials
      • eCOA Clinical Trials
      • eCOA Live
      • eCOA Multimedia
      • eCOA Rapid Start
      • eCOA Rater and Participant Training
      • eCOA Rescue Studies
      • Suicidal Ideation
    • Artificial Intelligence (AI)
    • Cardiac Solutions
      • Cardiac Solutions
      • Arrhythmia Analysis
      • Blood Pressure Services
      • ECG — On-site to DCT and Phase I-IV
      • Phase I/TQT Cardiac Assessment
      • Regulatory Consultation and Statistical Analysis Expertise
    • Medical Imaging
      • Medical Imaging
      • Medical Imaging science team
      • Image Redact AI
      • Imaging Platform
      • Modalities
      • SMART Submit
    • Precision Motion
      • Precision Motion for Clinical Trials
      • Precision Motion for Research
      • Precision Motion: Scientific Publications
    • Respiratory Solutions
      • Respiratory Solutions
      • Site-Based Spirometry (FEV1, FVC, PEF, and more.)
      • Virtual Home Spirometry
      • Cough and Lung Sounds
      • Diffusing Capacity (DLCO)
    • Trial Enablement
      • Trial Enablement
      • Clinical Adjudication
      • Eligibility Solution
      • Reporting & Analytics
      • Source Document Manager
    • Hybrid Trials
    • Biotechs
    • CROs
    • Pharma
    • Phase I
    • Phase II/III
  • Therapeutic Areas
    • Cardiovascular & Metabolic
    • Dermatology
    • Gastroenterology
    • Hepatology
    • Infectious Diseases
    • Musculoskeletal
    • Neuroscience
    • Oncology
    • Ophthalmology
    • Type 2 Diabetes and Obesity
    • Respiratory Solutions
  • Resources
    • Blog Articles
    • Case Studies
    • Downloads
    • Events
    • External Publications
    • Webinars
  • About
    • The Clario Story
    • Corporate & Social Responsibility
    • Information Security
    • Leadership
    • Legal & Privacy
    • Scientific Expertise
    • Strategic Partnerships
    • Values & Culture
  • Support
    • Customer Support
    • In-Country Cardiac Safety Support
  • Careers
    • Life at Clario
  • Newsroom
  • Login
  • Contact sales
    • Log in
    • Contact sales
  1. Home About Newsroom Clario and Cogstate expand partnership to deliver leading data collection and data quality programs for neuroscience clinical trials

Clario and Cogstate expand partnership to deliver leading data collection and data quality programs for neuroscience clinical trials

Collaboration combines Clario’s eCOA innovations with Cogstate’s expertise in neuroscience research to yield highest quality endpoint

  • Partnership expansion will help optimize neuroscience cognitive assessments in clinical trials to help bring new therapies to market faster
  • Combines Clario’s innovative eCOA Multimedia technologies for audio and photo capture with Cogstate’s global clinical network and therapeutic area expertise
  • Delivers both high data quality benefits and operational ease for patients and clinicians

PHILADELPHIA, PA – May 20, 2022 – Clario, a technology company that delivers the leading endpoint solutions for decentralized (DCT), hybrid and site-based clinical trials, announced today, on World Clinical Trials Day, an expansion of its partnership with cognitive science company, Cogstate, to jointly provide data quality solutions to support the unique requirements of neuroscience assessments for therapeutic development.

The collaboration drives enhanced data quality and signal detection for the full range of conventional cognitive endpoints common in neuroscience studies. It combines Clario’s eCOA Multimedia technology for audio, photo and patient/clinician data capture with Cogstate’s global clinical network and deep therapeutic expertise in neurodegenerative diseases. This expands the companies’ previously announced partnership to deliver Cogstate’s digital cognitive assessments with Clario’s eCOA platform offering a dramatically streamlined solution for digital and conventional outcomes with an integrated approach to hardware, training and operational support.

“Clinical trials, particularly those in neurodegenerative disease, require sensitive, reliable endpoints that are delivered with a streamlined, patient-centric approach, integrating the range of clinical assessments across performance-based, clinician-reported and patient-reported outcomes,” said Andrew Cooper, Executive Vice President, eCOA and Trial Enablement at Clario. “Fit-for-purpose eCOA functionality such as photo and audio capture and advanced workflow and scoring automations enable reliable and standardized data collection for cognitive endpoints when tightly coupled with industry-leading rater training and monitoring. That is what Cogstate and Clario have come together to deliver.”

“We are thrilled to expand our partnership with the eCOA experts at Clario to support the full range of cognitive and clinical assessments critical to neuroscience research,” said Brad O’Connor, Chief Executive Officer at Cogstate. “As a company, we have pioneered digital assessments of cognition as well as novel delivery models for rater training of conventional cognitive assessments. Effectively balancing data quality benefits with operational ease can only be achieved when you combine deep domain expertise with capable and flexible clinical systems. This expanded collaboration offers an approach that can meaningfully reduce rater and site burden while driving quality outcomes.”

Clinical Trials can transform and save lives. This partnership will continue to drive innovation for clinicians and patients. To learn more about Clario’s eCOA Multimedia, please navigate to the Clario eCOA Multimedia page.


About Cogstate

Cogstate Ltd (ASX:CGS) is a leading neuroscience technology company optimizing brain health assessments to advance the development of new medicines and to enable earlier clinical insights in healthcare. Cogstate technologies provide rapid, reliable and highly sensitive computerized cognitive tests and support electronic clinical outcome assessment (eCOA) solutions to replace costly and error-prone paper assessments with real-time data capture. For more than 20 years, Cogstate has proudly supported the leading-edge research needs of biopharmaceutical companies and academic institutions and the clinical care needs of physicians and patients around the world.

For more information, go to Cogstate.com or follow us on LinkedIn and Twitter.

About Clario

Clario is a leading technology company that generates the richest clinical evidence in the industry for our pharmaceutical, biotech and medical device partners. Across decentralized and site-based trials, our deep scientific expertise, global scale and the broadest endpoint technology platform in the industry allows our partners to transform lives. Clario’s solutions have been powering hybrid and decentralized clinical trials (DCT) for over 15 years, enabling sponsors to collect high-quality endpoint data from any modality or location, all while improving the patient experience and diversity. Clario has the only technology platform that combines eCOA, cardiac safety, medical imaging, precision motion and respiratory endpoints. With 30 facilities in nine countries, Clario’s global team of science, technology and operational experts has helped deliver over 19,000 trials and 870 regulatory for over 5m patients in 120 countries. Our innovation has been transforming clinical trials for 50 years.

For more information, go to Clario.com or follow us on LinkedIn and Twitter.

Clario Media Contact

Duncan Cantor
Sr. Director, PR and Thought Leadership
[email protected]

Back to newsroom
Share
Twitter Facebook LinkedIn

Related News

See all news

Clario Announces Completion of Acquisition of WCG’s eCOA Business

May 6, 2025 Read more

Clario collaborates with AWS to push new boundaries in clinical data analysis with generative AI 

April 16, 2025 Read more

Clario announces acquisition of imaging provider NeuroRx

March 17, 2025 Read more
Clario logo
    • Solutions
    • Therapeutic Areas
    • About
    • Resources
    • Careers
    • Newsroom
  • Get in touch

    • Contact
    • Support
    • Customer portal

Follow us

Twitter LinkedIn Glassdoor
×

Contact sales

If you are looking for a partner to help you generate the richest clinical evidence with the right clinical trial technology, please fill in the form below.


Not what you're looking for?

Please visit our Contact Page for customer support, office locations, or media contacts.

  • © 2025 Clario

    • Legal and Privacy Terms
    • Information Security
    • Cookie Policy
    • Impressum